Timber Hill’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-5,300
Closed -$373K 2424
2015
Q2
$373K Buy
5,300
+2,200
+71% +$163K ﹤0.01% 2058
2015
Q1
$246K Buy
+3,100
New +$229K ﹤0.01% 2128
2013
Q3
Sell
-13,500
Closed -$554K 3225
2013
Q2
$554K Buy
+13,500
New +$578K ﹤0.01% 2419

Other funds holding CRL

Timber Hill's CRL Position: Q4 2013 in Review

Timber Hill sold out of Charles River Laboratories (CRL) in Q4 2013, closing a stake of 5,901 shares — an estimated $273K sold.

Timber Hill first reported a position in CRL in Q3 2013 and held it in 1 quarter. The position peaked at $273K in Q3 2013. 239 funds tracked by Wall St. Rank hold CRL as of Q4 2013.

  • Timber Hill reported no remaining Charles River Laboratories position as of Q4 2013 after selling out during the quarter.
  • Timber Hill sold 5,901 Charles River Laboratories shares in Q4 2013, an estimated $273K.
  • Timber Hill first reported a position in Charles River Laboratories in Q3 2013 and held it in 1 quarter.
  • Timber Hill's Charles River Laboratories position peaked at $273K in Q3 2013.
  • 239 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2013.

Based on Timber Hill's 13F filing for Q4 2013, filed 14 Feb 2014.